期刊文献+

B_7基因转染联合LAK细胞治疗肝癌的体外研究 被引量:1

Experimental study on B_7 gene transfection combined with LAK-cells for liver carcinoma in vitro
下载PDF
导出
摘要 目的 :探讨体外诱导的 L AK细胞对 B7基因转染的肝癌细胞的杀伤作用。方法 :构建含人 B7- 1 基因 c DNA的真核表达载体 p RCCMV- B7- 1 ,脂质体介导转染法将 p RCCMV- B7- 1 转入人肝癌细胞系 SMMC772 1 ,G4 1 8筛选转染肝癌细胞 (B7+ SMMC772 1 )。RT- PCR、流式细胞仪鉴定目的基因表达。MTT比色试验体外检测 L AK细胞对 B7- 1 转染肝癌细胞的杀伤活性。结果 :B7+ SMMC772 1细胞稳定表达 B7基因。L AK细胞对 B7+ SMMC772 1细胞的杀伤活性明显高于野生型 SMMC772 1者 ,结果有统计学意义。结论 :B7基因体外转染人肝癌细胞后可表达有活性的 B7分子 ,L AK细胞对表达 B7- 1 ObjectiveTo study the killing effects of induced LAK cells on B 7 gene transfected cells of liver carcinoma. MethodsA new vector pRCCMV B 7 1 containing B 7 1 gene was constructed to establish the new cell line B 7 +SMMC7721 through transfection B 7 gene into the hepatocarcinoma cell SMMC7721 by liposome mediated transduction. RT PCR and flow cytometry were used to identify the expression of the transfected gene. MTT assay was used to evaluate the killing effects of LAK cells activated by IL 2 on the transfected line and the wild type of the cells. ResultsB 7 gene was steadily expressed in B 7 +SMMC7721 and LAK cells had effectively killing effects on the B 7 +SMMC7721 cells. ConclusionB 7 gene can be transfected into hepatocarcinoma cells and can be expressed steadily in vitro , which can increase the efficiency of LAK cells activated by IL 2 on them.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2004年第2期253-255,共3页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅资助课题 (吉科合字第 970 5 6 5 - 2号 )
关键词 肝细胞 基因 转染 共刺激分子 carcinoma,hepatocellular gene transfection costimulatory molecule
  • 相关文献

参考文献8

二级参考文献22

共引文献12

同被引文献10

  • 1Nel LH, Niezgoda M, Hanlon CA, et al. A comparison of DNA vaccines for the rabies-related virus, Mokola [J].Vaccine, 2003, 21 (19-20): 2598-2606.
  • 2Wang Y, Han KJ, Pang XW, et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies [J]. J Immunol, 2002, 169 (2): 1102-1109.
  • 3Rosenberg SA. A new era for cancer immunotherapy based on the genes that encode cancer antigens [J]. Immunity, 1999,10 (3):281-287.
  • 4Takahashi K, Shichijo S, Noguchi M, et al. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis [J]. Cancer Res, 1995, 55 ( 16),3478-3482.
  • 5Li G, Miles A, Line A, et al. Identification of tumour antigens by serological analysis of eDNA expression cloning [J].Cancer Immunol Immunother, 2004, 53 (3): 139-143.
  • 6Dhodapkar MV, Osman K, Teruya-Feldstein J, et al.Expression of cancer/testis (CT) antigens MAGEA1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease EJ3. Cancer Immun, 2003, 3: 9.
  • 7Scanlan MJ, Gure AO, Jungbluth AA, et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy [J]. Immunol Rev, 2002, 188z 22-32.
  • 8Chan RCF, Pang XW, Wang YD, et al. Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to targethepatoma cells [J]. Brit J Cancer, 2004, 90: 1636-1643.
  • 9管军,姚晓平,吴孟超,沈茜.微波组织凝固对晚期肝癌患者抗肿瘤免疫力的影响[J].中华物理医学杂志,1998,20(3):168-170. 被引量:48
  • 10杨璇,陈宗德,轩小燕.载体对癌胚抗原DNA疫苗在小鼠体内表达CEA及诱导体液免疫应答的影响[J].河南肿瘤学杂志,2003,16(2):81-82. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部